Increased β-Catenin/Tcf Signaling in Pilocytic Astrocytomas: A Comparative Study to Distinguish Pilocytic Astrocytomas from Low-Grade Diffuse Astrocytomas

被引:0
作者
Gangadhara Reddy Sareddy
Khamushavalli Geeviman
Manas Panigrahi
Sundaram Challa
Anita Mahadevan
Phanithi Prakash Babu
机构
[1] University of Hyderabad,Department of Biotechnology, School of Life Sciences
[2] Krishna Institute of Medical Sciences,Department of Neurosurgery
[3] Nizam Institute of Medical Sciences,Department of Pathology
[4] National Institute of Mental Health and Neuro Sciences,Department of Pathology
来源
Neurochemical Research | 2012年 / 37卷
关键词
Pilocytic astrocytoma; Diffuse astrocytoma; Differential expression; β-catenin;
D O I
暂无
中图分类号
学科分类号
摘要
Although pilocytic and diffuse grade II astrocytomas considered as low-grade tumors, the distinction between them is still a major clinical problem. Previously we reported the activation of Wnt/β-catenin/Tcf signaling pathway in diffuse astrocytomas, however its role in pilocytic astrocytomas is not well understood. In this study, we investigated the Wnt/β-catenin/Tcf pathway in pilocytic astrocytomas and compared with diffuse astrocytomas. We observed the differential expression of β-catenin, Tcf4, Lef1 and c-Myc in astrocytomas particularly higher levels were observed in pilocytic astrocytomas and GBM while very little expression was documented in grade II tumors. Further, immunohistochemical analysis revealed the strong positivity of β-catenin, Tcf4, Lef1 and c-Myc in pilocytic astrocytomas than that of grade II tumors and also exhibited the strong positivity in vascular endothelial cells of pilocytic astrocytomas and GBM. Hence, Wnt/β-catenin/Tcf signaling pathway is differentially expressed in astrocytomas, activation of this pathway might be helpful in separating pilocytic astrocytomas from low-grade diffuse astrocytomas.
引用
收藏
页码:96 / 104
页数:8
相关论文
共 46 条
  • [41] Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status
    Roth, Jacquelyn J.
    Fierst, Tamara M.
    Waanders, Angela J.
    Li Yimei
    Biegel, Jaclyn A.
    Santi, Mariarita
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2016, 75 (04) : 306 - 315
  • [42] Clinical, Morphological, and Molecular Study of Diffuse WHO Grade II and III Astrocytomas: A Retrospective Analysis from a Single Tertiary Care Institute
    Veduruvada, Ramya Lakshmi
    Uppin, Megha S.
    Konatam, Meher Lakshmi
    Alugolu, Rajesh
    Yeramneni, Vamsi Krishna
    Bhattacharjee, Suchanda
    Saradhi, Mudumba Vijaya
    Irukulla, Monica Malik
    Rao, Madhumohan
    Velugonda, Nagaraj
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (06) : 569 - 576
  • [43] Phenotypic variations in NF1-associated low grade astrocytomas: possible role for increased mTOR activation in a subset
    Jentoft, Mark
    Giannini, Caterina
    Cen, Ling
    Scheithauer, Bernd W.
    Hoesley, Bridget
    Sarkaria, Jann N.
    Abell-Aleff, Patrice C.
    Rodriguez, Erika F.
    Li, Ying
    Rodriguez, Fausto J.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2011, 4 (01): : 43 - 57
  • [44] A molecular study of pediatric pilomyxoid and pilocytic astrocytomas: Genome-wide copy number screening, retrospective analysis of clinicopathological features and long-term clinical outcome
    AlShail, Essam
    Alahmari, Ahmed Nasser
    Dababo, Anas A. M.
    Alsagob, Maysoon
    Al-Hindi, Hindi
    Khalil, Hala
    Al Masseri, Zainab
    AlSalamah, Razan
    Almohseny, Ethar
    Alduhaish, Amjad
    Colak, Dilek
    Kaya, Namik
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [45] SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups
    Kleinschmidt-DeMasters, B. K.
    Donson, Andrew M.
    Richmond, Abby M.
    Pekmezci, Melike
    Tihan, Tarik
    Foreman, Nicholas K.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2016, 75 (04) : 295 - 298
  • [46] Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target
    Huett-Cabezas, Marianne
    Karajannis, Matthias A.
    Zagzag, David
    Shah, Smit
    Horkayne-Szakaly, Iren
    Rushing, Elisabeth J.
    Cameron, J. Douglas
    Jain, Deepali
    Eberhart, Charles G.
    Raabe, Eric H.
    Rodriguez, Fausto J.
    NEURO-ONCOLOGY, 2013, 15 (12) : 1604 - 1614